Institutional investors purchased a net $3.0 million shares of ICPT during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 75.03% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST TRUST ADVISORS LP Bought 265.9 Thousand shares of Intercept Pharmaceuticals...